HIMS
Hims & Hers Health, Inc.
Price Chart
Latest Quote
$32.70
-0.26 (-0.79%)
Current Price
| Previous Close | $32.96 |
| Open | $32.60 |
| Day High | $33.74 |
| Day Low | $31.62 |
| Volume | 11,225,435 |
Stock Information
| Shares Outstanding | 223.08M |
| Total Debt | $1.13B |
| Cash Equivalents | $750.88M |
| Revenue | $2.37B |
| Net Income | $-13.23M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $7.57B |
| EPS (TTM) | $-0.09 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $8.01B |
| Sales | $2.37B |
| Income | $-13.23M |
| Book/sh | $1.93 |
| Cash/sh | $3.37 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 1.46 |
| Current Ratio | 1.69 |
| Debt/Eq | 253.72 |
Returns & Margins
| ROA | 0.60% |
| ROE | -2.66% |
| Gross Margin | 72.92% |
| Operating Margin | -7.90% |
| Profit Margin | -0.56% |
Ownership
| Insider Ownership | 5.52% |
| Institutional Ownership | 69.96% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 36.74 |
| PEG | 2.15 |
| P/S | 3.19 |
| P/B | 16.91 |
Analyst Data
| Recommendation | hold |
| Target Price | $27.32 |
Technical Indicators
| SMA20 | $29.08 |
| SMA50 | $27.42 |
| SMA200 | $33.15 |
| RSI | 62.43 |
| ATR | 2.5386 |
| Shares Float | 210.69M |
| Short Float | 32.57% |
| Short Ratio | 2.75 |
| Volatility | 2.40 |
| Rel Volume | 0.58 |
Performance History
| Week | +3.91% |
| Month | +37.68% |
| Quarter | +53.23% |
| 6 Months | -8.04% |
| YTD | -2.13% |
| Year | -22.11% |
| 3 Years | +278.03% |
| 5 Years | +177.82% |
| 10 Years | +233.67% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $32.70 | 11,225,435 |
| 2026-06-23 | $32.96 | 12,550,400 |
| 2026-06-22 | $33.54 | 22,866,900 |
| 2026-06-18 | $35.47 | 31,903,500 |
| 2026-06-17 | $31.89 | 23,154,100 |
| 2026-06-16 | $31.47 | 22,076,500 |
| 2026-06-15 | $30.17 | 22,980,500 |
| 2026-06-12 | $26.82 | 19,046,200 |
| 2026-06-11 | $28.87 | 13,860,900 |
| 2026-06-10 | $27.78 | 16,855,100 |
| 2026-06-09 | $28.98 | 25,446,000 |
| 2026-06-08 | $27.17 | 13,842,600 |
| 2026-06-05 | $26.19 | 18,614,000 |
| 2026-06-04 | $28.01 | 23,839,300 |
| 2026-06-03 | $27.51 | 13,789,000 |
| 2026-06-02 | $27.51 | 14,741,300 |
| 2026-06-01 | $27.76 | 21,146,300 |
| 2026-05-29 | $26.15 | 20,737,900 |
| 2026-05-28 | $25.38 | 12,883,700 |
| 2026-05-27 | $25.20 | 22,756,900 |
| 2026-05-26 | $23.85 | 16,605,500 |
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
đ° Latest News
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclaysâ Target Increase?
Insider Monkey âĸ 2026-06-24T13:27:40Z
Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks âĸ 2026-06-23T21:45:06Z
Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy
Simply Wall St. âĸ 2026-06-23T09:06:09Z
2 Unpopular Stocks That Deserve a Second Chance and 1 We Question
StockStory âĸ 2026-06-23T08:32:46Z
1 Surging Stock Worth Your Attention and 2 We Find Risky
StockStory âĸ 2026-06-22T09:47:19Z
HIMS Stock Slides Overnight: Insider Files Share Sale As CEO Teases Oura Wearable Integration
Stocktwits âĸ 2026-06-22T04:28:06Z
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Zacks âĸ 2026-06-19T13:00:04Z
Living Longer Is Big Business. These Stocks Will Benefit.
Barrons.com âĸ 2026-06-18T18:14:00Z
Hims & Hers Rallies With a July FDA Decision Looming
GuruFocus.com âĸ 2026-06-18T17:59:02ZHims & Hers Health, Inc. (HIMS) Ascends While Market Falls: Some Facts to Note
Zacks âĸ 2026-06-17T21:45:03Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $614,259,000 | $303,379,000 | $157,051,000 | $118,194,000 |
| Cost Of Revenue | $614,259,000 | $303,379,000 | $157,051,000 | $118,194,000 |
| Total Revenue | $2,347,637,000 | $1,476,514,000 | $872,000,000 | $526,916,000 |
| Operating Revenue | $2,347,637,000 | $1,476,514,000 | $872,000,000 | $526,916,000 |
| Expenses | ||||
| Total Expenses | $2,242,024,000 | $1,414,611,000 | $901,453,000 | $595,613,000 |
| Other Income Expense | $18,311,000 | $9,808,000 | $7,882,000 | $2,988,000 |
| Other Non Operating Income Expenses | $13,874,000 | $9,808,000 | $7,882,000 | $2,988,000 |
| Operating Expense | $1,627,765,000 | $1,111,232,000 | $744,402,000 | $477,419,000 |
| Other Operating Expenses | $286,444,000 | $185,802,000 | $119,857,000 | $77,403,000 |
| Selling And Marketing Expense | $919,296,000 | $678,844,000 | $446,435,000 | $272,587,000 |
| General And Administrative Expense | $272,724,000 | $167,767,000 | $129,883,000 | $98,192,000 |
| Interest Expense | - | - | - | - |
| Net Non Operating Interest Income Expense | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $128,365,000 | $126,038,000 | $-23,546,000 | $-65,678,000 |
| Normalized Income | $124,859,770 | $126,038,000 | $-23,546,000 | $-65,678,000 |
| Net Income From Continuing And Discontinued Operation | $128,365,000 | $126,038,000 | $-23,546,000 | $-65,678,000 |
| Total Operating Income As Reported | $105,613,000 | $61,903,000 | $-29,453,000 | $-68,697,000 |
| Net Income Common Stockholders | $128,365,000 | $126,038,000 | $-23,546,000 | $-65,678,000 |
| Net Income | $128,365,000 | $126,038,000 | $-23,546,000 | $-65,678,000 |
| Net Income Including Noncontrolling Interests | $128,365,000 | $126,038,000 | $-23,546,000 | $-65,678,000 |
| Net Income Continuous Operations | $128,365,000 | $126,038,000 | $-23,546,000 | $-65,678,000 |
| Pretax Income | $123,924,000 | $71,711,000 | $-21,571,000 | $-65,709,000 |
| Operating Income | $105,613,000 | $61,903,000 | $-29,453,000 | $-68,697,000 |
| Gross Profit | $1,733,378,000 | $1,173,135,000 | $714,949,000 | $408,722,000 |
| Net Interest Income | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $0.51 | $0.53 | $-0.11 | $-0.32 |
| Basic EPS | $0.57 | $0.58 | $-0.11 | $-0.32 |
| Other | ||||
| Tax Effect Of Unusual Items | $931,770 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $155,678,000 | $78,991,000 | $-19,938,000 | $-61,223,000 |
| Total Unusual Items | $4,437,000 | - | - | $70,000 |
| Total Unusual Items Excluding Goodwill | $4,437,000 | - | - | $70,000 |
| Reconciled Depreciation | $54,502,000 | $17,088,000 | $9,515,000 | $7,474,000 |
| EBITDA (Bullshit earnings) | $160,115,000 | $78,991,000 | $-19,938,000 | $-61,223,000 |
| EBIT | $105,613,000 | $61,903,000 | $-29,453,000 | $-68,697,000 |
| Diluted Average Shares | $258,230,547 | $236,808,876 | $209,344,712 | $204,516,120 |
| Basic Average Shares | $224,959,268 | $215,939,037 | $209,344,712 | $204,516,120 |
| Diluted NI Availto Com Stockholders | $128,365,000 | $126,038,000 | $-23,546,000 | $-65,678,000 |
| Tax Provision | $-4,441,000 | $-54,327,000 | $1,975,000 | $-31,000 |
| Gain On Sale Of Security | $4,437,000 | - | - | $70,000 |
| Research And Development | $149,301,000 | $78,819,000 | $48,227,000 | $29,237,000 |
| Selling General And Administration | $1,192,020,000 | $846,611,000 | $576,318,000 | $370,779,000 |
| Other Gand A | $272,724,000 | $167,767,000 | $129,883,000 | $98,192,000 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $66,487,000 | $320,578,000 | $214,574,000 | $179,019,000 |
| Total Assets | $2,154,705,000 | $707,539,000 | $441,186,000 | $366,341,000 |
| Total Non Current Assets | $1,387,067,000 | $311,708,000 | $176,133,000 | $149,746,000 |
| Other Non Current Assets | $29,680,000 | $1,003,000 | $947,000 | $889,000 |
| Non Current Deferred Assets | $82,707,000 | $61,603,000 | $0 | - |
| Non Current Deferred Taxes Assets | $82,707,000 | $61,603,000 | $0 | - |
| Investmentin Financial Assets | $351,263,000 | $0 | - | - |
| Goodwill And Other Intangible Assets | $474,441,000 | $156,138,000 | $129,455,000 | $132,722,000 |
| Other Intangible Assets | $196,116,000 | $43,410,000 | $18,574,000 | $21,841,000 |
| Current Assets | $767,638,000 | $395,831,000 | $265,053,000 | $216,595,000 |
| Other Current Assets | $4,374,000 | $400,000 | $4,195,000 | $1,785,000 |
| Prepaid Assets | $73,495,000 | $24,673,000 | $10,665,000 | $10,392,000 |
| Inventory | $80,128,000 | $64,427,000 | $22,464,000 | $21,562,000 |
| Receivables | $32,149,000 | $6,080,000 | $6,748,000 | $3,231,000 |
| Accounts Receivable | $32,149,000 | $6,080,000 | $6,748,000 | $3,231,000 |
| Cash Cash Equivalents And Short Term Investments | $577,492,000 | $300,251,000 | $220,981,000 | $179,625,000 |
| Cash And Cash Equivalents | $228,616,000 | $220,584,000 | $96,663,000 | $46,772,000 |
| Current Deferred Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $743,964,000 | - | - | - |
| Total Debt | $1,120,590,000 | $11,345,000 | $9,948,000 | $5,307,000 |
| Long Term Debt And Capital Lease Obligation | $1,115,747,000 | $9,456,000 | $8,667,000 | $3,649,000 |
| Long Term Debt | $972,580,000 | - | - | - |
| Current Debt And Capital Lease Obligation | $4,843,000 | $1,889,000 | $1,281,000 | $1,658,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,613,777,000 | $230,823,000 | $97,157,000 | $54,600,000 |
| Total Non Current Liabilities Net Minority Interest | $1,209,346,000 | $9,456,000 | $8,689,000 | $6,659,000 |
| Other Non Current Liabilities | $64,743,000 | - | $22,000 | $3,010,000 |
| Non Current Deferred Liabilities | $28,856,000 | $0 | - | - |
| Non Current Deferred Taxes Liabilities | $28,856,000 | $0 | - | - |
| Current Liabilities | $404,431,000 | $221,367,000 | $88,468,000 | $47,941,000 |
| Other Current Liabilities | $3,646,000 | - | - | - |
| Current Deferred Liabilities | $127,160,000 | $75,285,000 | $7,733,000 | $1,472,000 |
| Payables And Accrued Expenses | $268,782,000 | $144,193,000 | $79,454,000 | $44,811,000 |
| Payables | $199,900,000 | $93,332,000 | $50,482,000 | $33,326,000 |
| Other Payable | $46,986,000 | - | $7,412,000 | - |
| Total Tax Payable | $9,636,000 | $2,152,000 | $2,009,000 | $963,000 |
| Accounts Payable | $143,278,000 | $91,180,000 | $43,070,000 | $32,363,000 |
| Equity | ||||
| Common Stock Equity | $540,928,000 | $476,716,000 | $344,029,000 | $311,741,000 |
| Total Equity Gross Minority Interest | $540,928,000 | $476,716,000 | $344,029,000 | $311,741,000 |
| Stockholders Equity | $540,928,000 | $476,716,000 | $344,029,000 | $311,741,000 |
| Gains Losses Not Affecting Retained Earnings | $2,294,000 | $-324,000 | $-124,000 | $-277,000 |
| Other Equity Adjustments | $2,294,000 | $-324,000 | $-124,000 | $-277,000 |
| Retained Earnings | $-113,772,000 | $-242,137,000 | $-368,175,000 | $-344,629,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $227,245,521 | $220,837,209 | $213,481,743 | $208,429,312 |
| Share Issued | $227,245,521 | $220,837,209 | $213,481,743 | $208,429,312 |
| Tangible Book Value | $66,487,000 | $320,578,000 | $214,574,000 | $179,019,000 |
| Invested Capital | $1,513,508,000 | $476,716,000 | $344,029,000 | $311,741,000 |
| Working Capital | $363,207,000 | $174,464,000 | $176,585,000 | $168,654,000 |
| Capital Lease Obligations | $148,010,000 | $11,345,000 | $9,948,000 | $5,307,000 |
| Total Capitalization | $1,513,508,000 | $476,716,000 | $344,029,000 | $311,741,000 |
| Additional Paid In Capital | $652,383,000 | $719,155,000 | $712,307,000 | $656,626,000 |
| Capital Stock | $23,000 | $22,000 | $21,000 | $21,000 |
| Common Stock | $23,000 | $22,000 | $21,000 | $21,000 |
| Long Term Capital Lease Obligation | $143,167,000 | $9,456,000 | $8,667,000 | $3,649,000 |
| Current Deferred Revenue | $127,160,000 | $75,285,000 | $7,733,000 | $1,472,000 |
| Current Capital Lease Obligation | $4,843,000 | $1,889,000 | $1,281,000 | $1,658,000 |
| Current Accrued Expenses | $68,882,000 | $50,861,000 | $28,972,000 | $11,485,000 |
| Investments And Advances | $351,263,000 | $0 | - | - |
| Available For Sale Securities | $351,263,000 | - | - | - |
| Goodwill | $278,325,000 | $112,728,000 | $110,881,000 | $110,881,000 |
| Net PPE | $448,976,000 | $92,964,000 | $45,731,000 | $16,135,000 |
| Accumulated Depreciation | $-52,589,000 | $-24,499,000 | $-12,244,000 | $-6,241,000 |
| Gross PPE | $501,565,000 | $117,463,000 | $57,975,000 | $22,376,000 |
| Leases | $15,925,000 | $10,933,000 | $2,256,000 | $155,000 |
| Other Properties | $351,329,000 | $44,645,000 | $24,495,000 | $6,568,000 |
| Machinery Furniture Equipment | $134,311,000 | $61,885,000 | $31,224,000 | $15,653,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $26,977,000 | $35,077,000 | $15,221,000 | $16,477,000 |
| Raw Materials | $53,151,000 | $29,350,000 | $7,243,000 | $5,085,000 |
| Other Short Term Investments | $348,876,000 | $79,667,000 | $124,318,000 | $132,853,000 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $57,415,000 | $198,334,000 | $46,991,000 | $-33,778,000 |
| Operating Activities | ||||
| Operating Cash Flow | $300,006,000 | $251,084,000 | $73,483,000 | $-26,531,000 |
| Cash Flow From Continuing Operating Activities | $300,006,000 | $251,084,000 | $73,483,000 | $-26,531,000 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-242,591,000 | $-52,750,000 | $-26,492,000 | $-7,247,000 |
| Investing Cash Flow | $-1,024,958,000 | $-19,048,000 | $-12,106,000 | $34,699,000 |
| Cash Flow From Continuing Investing Activities | $-1,024,958,000 | $-19,048,000 | $-12,106,000 | $34,699,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-89,960,000 | $-83,039,000 | $-1,999,000 | $0 |
| Financing Cash Flow | $729,620,000 | $-107,845,000 | $-11,475,000 | $-33,127,000 |
| Cash Flow From Continuing Financing Activities | $729,620,000 | $-107,845,000 | $-11,475,000 | $-33,127,000 |
| Net Other Financing Charges | $-167,893,000 | $-55,691,000 | $-14,096,000 | $-36,551,000 |
| Net Common Stock Issuance | $-89,960,000 | $-83,039,000 | $-1,999,000 | $0 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Issuance Of Debt | $970,000,000 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $23,162,000 | $7,916,000 | $1,109,000 | $636,000 |
| End Cash Position | $228,616,000 | $221,440,000 | $97,519,000 | $47,628,000 |
| Beginning Cash Position | $221,440,000 | $97,519,000 | $47,628,000 | $72,640,000 |
| Effect Of Exchange Rate Changes | $2,508,000 | $-270,000 | $-11,000 | $-53,000 |
| Changes In Cash | $4,668,000 | $124,191,000 | $49,902,000 | $-24,959,000 |
| Proceeds From Stock Option Exercised | $17,473,000 | $30,885,000 | $4,620,000 | $3,424,000 |
| Common Stock Payments | $-89,960,000 | $-83,039,000 | $-1,999,000 | $0 |
| Net Issuance Payments Of Debt | $970,000,000 | $0 | $0 | $0 |
| Net Long Term Debt Issuance | $970,000,000 | $0 | $0 | $0 |
| Long Term Debt Issuance | $970,000,000 | $0 | $0 | $0 |
| Net Investment Purchase And Sale | $-637,140,000 | $49,101,000 | $14,386,000 | $42,405,000 |
| Sale Of Investment | $108,698,000 | $209,665,000 | $171,625,000 | $230,105,000 |
| Purchase Of Investment | $-745,838,000 | $-160,564,000 | $-157,239,000 | $-187,700,000 |
| Net Business Purchase And Sale | $-145,227,000 | $-15,399,000 | $0 | $-459,000 |
| Purchase Of Business | $-145,227,000 | $-15,399,000 | $0 | $-459,000 |
| Net Intangibles Purchase And Sale | $-16,546,000 | $-11,095,000 | $-9,272,000 | $-4,533,000 |
| Purchase Of Intangibles | $-16,546,000 | $-11,095,000 | $-9,272,000 | $-4,533,000 |
| Net PPE Purchase And Sale | $-226,045,000 | $-41,655,000 | $-17,220,000 | $-2,714,000 |
| Purchase Of PPE | $-226,045,000 | $-41,655,000 | $-17,220,000 | $-2,714,000 |
| Change In Working Capital | $-29,161,000 | $78,623,000 | $20,821,000 | $-14,195,000 |
| Change In Other Working Capital | $51,604,000 | $67,552,000 | $6,261,000 | $-1,716,000 |
| Change In Other Current Liabilities | $-1,913,000 | $-2,443,000 | $-1,933,000 | $-1,605,000 |
| Change In Other Current Assets | $-518,000 | $-56,000 | $-58,000 | $17,000 |
| Change In Payables And Accrued Expense | $-12,756,000 | $64,676,000 | $23,848,000 | $3,448,000 |
| Change In Accrued Expense | $-43,053,000 | $23,791,000 | $16,524,000 | $909,000 |
| Change In Payable | $30,297,000 | $40,885,000 | $7,324,000 | $2,539,000 |
| Change In Account Payable | $30,297,000 | $43,710,000 | $7,324,000 | $12,723,000 |
| Change In Prepaid Assets | $-51,856,000 | $-9,494,000 | $-6,395,000 | $-6,335,000 |
| Change In Inventory | $-13,722,000 | $-41,612,000 | $-902,000 | $-8,004,000 |
| Other Non Cash Items | $29,955,000 | $2,903,000 | $5,883,000 | $2,372,000 |
| Stock Based Compensation | $135,244,000 | $92,322,000 | $66,080,000 | $42,817,000 |
| Unrealized Gain Loss On Investment Securities | $-4,437,000 | $0 | $0 | - |
| Asset Impairment Charge | $531,000 | $114,000 | $429,000 | $1,127,000 |
| Amortization Of Securities | $-2,032,000 | $-4,355,000 | $-5,686,000 | $146,000 |
| Deferred Tax | $-12,961,000 | $-61,649,000 | $-13,000 | $-594,000 |
| Deferred Income Tax | $-12,961,000 | $-61,649,000 | $-13,000 | $-594,000 |
| Depreciation Amortization Depletion | $54,502,000 | $17,088,000 | $9,515,000 | $7,474,000 |
| Depreciation And Amortization | $54,502,000 | $17,088,000 | $9,515,000 | $7,474,000 |
| Net Income From Continuing Operations | $128,365,000 | $126,038,000 | $-23,546,000 | $-65,678,000 |
| Repayment Of Debt | - | - | - | $0 |
| Interest Paid Supplemental Data | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-06-22